Skip to content

Pulsed Short Wave Therapy In Cesarean Section

Protocol For The Randomized Controlled Trial Of Pulsed Short Wave Therapy In Cesarean Section

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03604068
Enrollment
250
Registered
2018-07-27
Start date
2018-04-01
Completion date
2018-12-30
Last updated
2018-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

Caesarean section

Brief summary

This clinical study is designed to assesses the benefit of adding pulsed shortwave therapy to the postoperative pain and recovery protocol following Cesarean section. Pulsed shortwave therapy is a safe adjunct pain therapy for acute and chronic pain.

Detailed description

Pain is ranked highest among undesirable clinical outcomes associated with caesarean section therefore postoperative pain relief following a cesarean section is extremely important to optimize maternal and neonate well being. Multimodial analgesics are effective in reducing postoperative pain but analgesia is still not optimized. Opiate based analgesics are effective but having troubling side effects. Addition of non-drug pain therapies hold promise in improving postoperative recovery while potentially allowing for reduced use of drug based analgesics.

Interventions

DEVICERecoveryRx

A pulsed shortwave therapy medical device

DEVICESham RecoveryRx

A sham pulsed shortwave therapy medical device

Sponsors

BioElectronics Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Voluntarily * Performed using spinal anesthesia * ASA I (Normal healthy patients) and II (Patients with mild systemic disease) (as defined by the American Society of Anesthesiologists Physical Status Classification system) * PARA 0000, 1, 2, 3 \[i.e. First, Second, or Third C-Section) * At term pregnancy (\>38 weeks) * BMI \<35 * Age between 18 - 50 years

Exclusion criteria

* Longitudinal surgical incision * Placental abnormalities noted * Time of extraction of the fetus \>10 min from cutaneous incision * Blood loss during surgery of \>800 ml * Any of the conditions not considered in inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Medication UseData collected daily for 7 DaysQuantify the use of analgesic medications during 7 days of postoperative recovery.

Secondary

MeasureTime frameDescription
Change in Visual Analogue PainData collected for 7 DaysThe visual analog scale (VAS) has been used extensively for rating pain intensity in previous studies. Postoperative pain will be measured daily over a 7 day recovery period
Time to patient Patient Mobility2 DaysThe benefits of mobility outlined in current nursing textbooks indicate that Early ambulation is the most significant general nursing measure to prevent postoperative complications. There the time in hours after the c-section operation when the patient becomes mobile(walking) will be used recorded.
Would Closure at Day 7, Wound Complications7 Dayspresence of edema, erythema,hematoma, and exudate from the surgical wound on the seventh postoperative day that could impair woundhealing process

Countries

Lebanon

Contacts

Primary ContactMahmoud Maassarani, Ph.D
M.maassarani@outlook.fr79156547
Backup ContactOmar Tabbouche, Pharma D
omartabbouche@gmail.com03433032

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026